AU2022376433A1 - Tumor microenvironment types in breast cancer - Google Patents
Tumor microenvironment types in breast cancer Download PDFInfo
- Publication number
- AU2022376433A1 AU2022376433A1 AU2022376433A AU2022376433A AU2022376433A1 AU 2022376433 A1 AU2022376433 A1 AU 2022376433A1 AU 2022376433 A AU2022376433 A AU 2022376433A AU 2022376433 A AU2022376433 A AU 2022376433A AU 2022376433 A1 AU2022376433 A1 AU 2022376433A1
- Authority
- AU
- Australia
- Prior art keywords
- group
- tme
- hla
- signature
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163273171P | 2021-10-29 | 2021-10-29 | |
| US63/273,171 | 2021-10-29 | ||
| PCT/US2022/048191 WO2023076574A1 (en) | 2021-10-29 | 2022-10-28 | Tumor microenvironment types in breast cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2022376433A1 true AU2022376433A1 (en) | 2024-05-09 |
Family
ID=84421443
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2022376433A Pending AU2022376433A1 (en) | 2021-10-29 | 2022-10-28 | Tumor microenvironment types in breast cancer |
Country Status (5)
| Country | Link |
|---|---|
| EP (2) | EP4423301B1 (https=) |
| JP (1) | JP2024541909A (https=) |
| AU (1) | AU2022376433A1 (https=) |
| CA (1) | CA3236872A1 (https=) |
| WO (1) | WO2023076574A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202540200A (zh) | 2023-12-01 | 2025-10-16 | 美商基利科學股份有限公司 | 抗ｆａｐ－ｌｉｇｈｔ融合蛋白及其用途 |
| WO2025259871A1 (en) | 2024-06-14 | 2025-12-18 | Gilead Sciences, Inc. | Anti-ccr8 antibodies and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202209539D0 (en) | 2017-06-13 | 2022-08-10 | Bostongene Corp | Systems and methods for identifying cancer treatments from normalized biomarker scores |
| US11988672B2 (en) * | 2019-11-26 | 2024-05-21 | University Of South Carolina | CCL24 as a diagnostic and therapeutic target for breast cancer |
| JP7541585B2 (ja) | 2020-03-12 | 2024-08-28 | ボストンジーン コーポレイション | 発現データのデコンボリューションのためのシステム及び方法 |
-
2022
- 2022-10-28 EP EP22818527.8A patent/EP4423301B1/en active Active
- 2022-10-28 AU AU2022376433A patent/AU2022376433A1/en active Pending
- 2022-10-28 EP EP25212124.9A patent/EP4692374A3/en active Pending
- 2022-10-28 WO PCT/US2022/048191 patent/WO2023076574A1/en not_active Ceased
- 2022-10-28 JP JP2024524493A patent/JP2024541909A/ja active Pending
- 2022-10-28 CA CA3236872A patent/CA3236872A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023076574A1 (en) | 2023-05-04 |
| EP4423301B1 (en) | 2025-12-10 |
| JP2024541909A (ja) | 2024-11-13 |
| EP4692374A2 (en) | 2026-02-11 |
| EP4692374A3 (en) | 2026-04-22 |
| CA3236872A1 (en) | 2023-05-04 |
| EP4423301A1 (en) | 2024-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7401710B2 (ja) | 正規化バイオマーカースコアからがん治療を特定するためのシステム及び方法 | |
| US20220319638A1 (en) | Predicting response to treatments in patients with clear cell renal cell carcinoma | |
| EP4244394B1 (en) | Techniques for identifying follicular lymphoma types | |
| EP4423301B1 (en) | Tumor microenvironment types in breast cancer | |
| US20230290440A1 (en) | Urothelial tumor microenvironment (tme) types | |
| US20260038698A1 (en) | Pan-cancer tumor microenvironment classification based on immune escape mechanisms and immune infiltration | |
| US20220307088A1 (en) | B cell-enriched tumor microenvironments | |
| US20220290254A1 (en) | B cell-enriched tumor microenvironments | |
| US20260120879A1 (en) | Machine learning technique for identifying ici responders and non-responders | |
| WO2024151840A1 (en) | Tumor microenvironment types in lung adenocarcinoma | |
| HK40017854B (en) | Systems and methods for identifying cancer treatments from normalized biomarker scores | |
| HK40017854A (en) | Systems and methods for identifying cancer treatments from normalized biomarker scores |